CINCINNATI--(BUSINESS WIRE)--In response to the novel coronavirus (COVID-19) pandemic, the Vicks® family of cold and flu brands – NyQuil™, DayQuil™ and VapoRub™ – will donate $1 million to Direct Relief, one of the world’s largest medical relief organizations. These funds will go toward equipping front line health workers with protective gear and providing medicines and equipment needed to treat an anticipated spike in ICU patients. The organization is also working to expand medical assistance to safety-net health facilities where chronic gaps are expected to widen.
“Direct Relief is deeply grateful to Vicks for their leadership and generosity during this challenging time,” said Thomas Tighe, President and CEO of Direct Relief. “As cases continue to grow, private industry has an extraordinary ability to collaborate for the public good, and Vicks is leading by example.”
“As a leader in consumer health for more than 125 years, Vicks has always focused on providing care and promoting relief in times of need,” said Paul Gama, President-Elect, Global P&G Personal Health Care. “This time is no different – we must come together to help those most in need, which is why Vicks is helping to support health care workers on the front line.”
Direct Relief is a humanitarian aid organization that aims to improve the health and lives of people affected by poverty or emergencies, including COVID-19.
For more information, or if you would also like to donate to this cause, please visit Direct Relief and follow Vicks on Facebook and Instagram. You can also follow Direct Relief’s Twitter, Facebook and Instagram channels.
ABOUT DIRECT RELIEF
A humanitarian organization committed to improving the health and lives of people affected by poverty or emergencies, Direct Relief delivers lifesaving medical resources throughout the world to communities in need—without regard to politics, religion, or ability to pay. For more information, please visit https://www.DirectRelief.org.
Vicks is one of the most recognized brands around the world. Available in more than 74 countries and on 5 continents, Vicks has helped relieve cough, cold, and flu symptoms for generations. In the U.S., the Vicks family includes, NyQuil™, the #1 Pharmacist recommended brand for Cough, Cold and Flu Combinations for Nighttime Category*; NyQuil™ SEVERE; Children’s NyQuil™; DayQuil™, the #1 Pharmacist recommended brand for Cough, Cold and Flu Combinations for Daytime Category*; DayQuil™ SEVERE; DayQuil™ Cough; VapoRub™ and VapoRub™ Children’s Ointment, the #1 Pharmacist recommended brand for Topical Cough Suppressing Ointment*; VapoRub™ Lavender; VapoRub™ Lemon; BabyRub™; Sinex™ 12 Hour Spray; Sinex™ Ultra Fine Mist; Sinex™ 12 Hour Ultra Fine Mist Moisturizing; Sinex™ SEVERE Congestion LiquiCaps; Sinex™ SEVERE Pressure & Pain LiquiCaps; Formula 44™ Cough; Formula 44™ Cough & Chest Congestion; Formula 44™ Cough & Head Congestion; Formula 44™ Nighttime Cough & Cold; VapoInhaler™, the #1 Pharmacist recommended brand for Non-Medicated Nasal Decongestant Inhaler Category*; DayQuil™ SEVERE with VapoCOOL™, NyQuil™ SEVERE with VapoCOOL™, Sinex™ SEVERE with VapoCOOL™ Nighttime Congestion, Formula 44™ with VapoCOOL™ SEVERE Nighttime Cough & Cold, Vicks® VapoCOOL™ Medicated Drops and Vicks® VapoDrops™. Headquartered in Cincinnati, OH, Vicks is owned and distributed by Procter & Gamble.
ABOUT PROCTER & GAMBLE
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com/ for the latest news and information about P&G and its brands.
*Data represents brand/product selections from the 2019 Pharmacy Times Survey of Pharmacists’ OTC Recommendations.